Related Experiment Video

Updated: Oct 2, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.1K

SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52

Yuchao Diao1,2, Yingwei Li3,4, Zixiang Wang1

  • 1Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Cell Death & Disease
|February 25, 2022
PubMed

Insights

SF3B4 splicing factor is upregulated in ovarian cancer (OC), promoting tumor growth and poor prognosis. It targets RAD52, and is regulated by miR-509-3p, suggesting potential therapeutic strategies for OC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Splicing factors are critical in human malignant tumor development.
  • The role and expression of SF3B4 in ovarian cancer (OC) remain unclear.

Purpose of the Study:

  • To investigate the expression, function, and regulatory mechanisms of SF3B4 in ovarian cancer.
  • To explore SF3B4 as a potential therapeutic target and biomarker for OC.

Main Methods:

  • Quantitative analysis of SF3B4 expression in OC patients.
  • In vitro and in vivo assays to assess the functional impact of SF3B4.
  • Analysis of microRNA (miRNA) regulation of SF3B4.
  • Alternative splicing analysis to identify SF3B4 targets, including RAD52.

Main Results:

  • SF3B4 is significantly upregulated in OC and correlates with poor patient prognosis.
  • SF3B4 overexpression enhances OC cell proliferation and migration; its downregulation inhibits these processes.
  • miR-509-3p directly targets SF3B4 mRNA, reducing its expression.
  • SF3B4 promotes OC progression by facilitating RAD52 splicing, specifically through intron 8 retention, leading to premature termination codons.

Conclusions:

  • SF3B4, regulated by miR-509-3p, drives ovarian cancer progression via RAD52 splicing.
  • SF3B4 represents a potential diagnostic biomarker and therapeutic target for ovarian cancer.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.8K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.9K

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.8K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K